Actelion Shareholders Reject Biotech Firm's Pay Plans

18.04.2013 - Actelion shareholders rejected a $5.6 million pay award for the biotechnology company's chief executive Jean-Paul Clozel on Thursday, making it the second Swiss company in as many...